Cargando…
Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids
Rationale: To test whether novel biomarkers, such as microribonucleic acids (miRNAs), and nonstandard predictive models, such as decision tree learning, provide useful information for medical decision-making in patients on hemodialysis (HD). Methods: Samples from patients with end-stage renal diseas...
Autores principales: | de Gonzalo-Calvo, David, Martínez-Camblor, Pablo, Bär, Christian, Duarte, Kevin, Girerd, Nicolas, Fellström, Bengt, Schmieder, Roland E., Jardine, Alan G., Massy, Ziad A., Holdaas, Hallvard, Rossignol, Patrick, Zannad, Faiez, Thum, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392028/ https://www.ncbi.nlm.nih.gov/pubmed/32754270 http://dx.doi.org/10.7150/thno.46123 |
Ejemplares similares
-
Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial
por: Salib, Madonna, et al.
Publicado: (2021) -
Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial
por: Girerd, Sophie, et al.
Publicado: (2019) -
Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study
por: Fellström, Bengt, et al.
Publicado: (2005) -
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients
por: Rossignol, P, et al.
Publicado: (2022) -
Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post‐discharge
por: Rossignol, Patrick, et al.
Publicado: (2020)